Perfil sociodemográfico e farmacoterapêutico de pessoas transgêneros acompanhadas por um serviço ambulatorial especializado no nordeste do Brasil

Autores

DOI:

https://doi.org/10.33448/rsd-v11i15.37659

Palavras-chave:

Identidade de gênero; Serviços de saúde para pessoas transgênero; Hormônios; Pessoas transgênero; Sistema único de saúde.

Resumo

This study describes the sociodemographic and pharmacotherapeutic profile of transgender persons from a specialized outpatient service in Sergipe, northeast of Brazil. This investigation is an observational, cross-sectional, and retrospective research developed from January to May 2022 with a convenience sampling. Data included in the analysis was the number of medical records, age, gender, years of education, and marital status. Also collected from electronic medical records information about drug utilization, such as the type of hormone therapy and other medications currently used, whether prescribed or not. The descriptive analysis involved measures of central tendency (mean, median, and standard deviation). Transgender people included in the study (n=81) were up to 29 (80%) (mean age of 26 years), and 70% (n=57) reported the use of hormone therapy; 17% (n=10) reported consuming it by self-medication. The most used formulation was testosterone cypionate 40.8% (n=20), followed by cyproterone acetate plus estradiol 20.4% (n=10). About 66.7% (n=38) of these people used other medications, as antidepressants (32%; n=24). As a minority population constantly facing situations of social vulnerability, this work will contribute to a more detailed characterization of this population from the investigated service, and then public agencies and organizations that serve this population can obtain more information about the diversity that composes it.

Biografia do Autor

Luiz Eduardo Oliveira Matos, Federal University of Sergipe

Farmacêutico (2016) pela Universidade Federal de Sergipe (UFS). Residente Programa Multiprofissional de Pós Graduação em Atenção Hospitalar à Saúde (HUL-UFS/EBSERH). Pesquisador no Núcleo Transdisciplinar de Estudos em Saúde Coletiva (NUTESC).

Referências

Arán, M., Murta, D. & Lionço, T. (2009). Transsexuality and Public Health in Brazil Cien Saude Colet,14(4):1141-9; 10.1590/S1413-81232009000400020.

Augusto, R. M., Oliveira, D. C. & Polidoro, M. (2020). Description of Medications Prescribed for Hormone Therapy in Specialized Health Services for Transsexuals and Transvestites in Rio Grande Do Sul, Brazil. Epidemiol Serv Saude, 31(1):e2021502; 10.1590/s1679-49742022000100027.

Brazil (2001). National Medicines Policy. Brasília.

Barreto, M. L. & Filho, N. A. (2011). Epidemiologia & Saúde: Fundamentos, Métodos e Aplicações–parte 2. Koogan

Brazil (2013). Ordinance No. 2,803, of November 19, 2013. Brasília.

Brazil (2011). Ordinance No. 2,836, of December 1, 2011. Brasília.

Bretherton, I. et al. (2019). Cross-Sex Hormone Therapy in Australia: The Prescription Patterns of Clinicians Experienced in Adult Transgender Healthcare: Transgender Hormone Therapy Prescribing Patterns. Intern Med J , 49(2):182–188; 10.1111/imj.14035.

CEDEC - Center for the Study of Contemporary Culture. (2021). Mapping of Trans People in the Municipality of São Paulo. Sao Paulo; 2021.

Chaudhary, S., Ray, R. & Glass, B. (2021). Pharmacists’ Role in Transgender Healthcare: A Scoping Review. Res Soc Adm Pharm 2021;17(9):1553-1561; 10.1016/j.sapharm.2020.12.015.

Cheung, A. S. et al. (2018). Sociodemographic and Clinical Characteristics of Transgender Adults in Australia. Transgend Health, 3(1):229–238; 10.1089/trgh.2018.0019.

Feldman, J. L. et al. (2021). Health and Health Care Access in the US Transgender Population Health (TransPop) Survey. Andrology 9(6):1707–1718; 10.1111/andr.13052.

Freire, M. A. et al. (2014). Hamilton Scale: Study of Psychometric Characteristics in a Sample from Southern Brazil. J. bras. psiquiatr., 63(4):281–289; 10.1590/0047-2085000000036.

Grinsztejn, B. et al. (2017). Unveiling of HIV Dynamics among Transgender Women: A Respondent-Driven Sampling Study in Rio de Janeiro, Brazil. Lancet HIV, 4(4):e169–e176; 10.1016/S2352-3018(17)30015-2.

Krüger, A. et al. (2019). Characteristics of Hormone Use by Travestis and Transgender Women of the Brazilian Federal District, Brazil, Rev Bras Epidemiol 22(suppl 1) 10.1590/1980-549720190004.

Maraka, S. et al. (2017). Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab , 102(11):3914–3923; 10.1210/jc.2017-01643.

Martins, T. A. et al. (2013). Travestis , an Unexplored Population at Risk of HIV in a Large Metropolis of Northeast Brazil: A Respondent-Driven Sampling Survey. AIDS Care, 25(5):606–612; 10.1080/09540121.2012.726342.

Ministry of Health. Pharmaceutical Care in Primary Care. (2014).

Pinto, T. P. et al. (2017). Industrial Liquid Silicone to Transform the Body: Prevalence and Factors Associated with Its Use Among Transvestites and Transgender Women in São Paulo, Brazil. Cad Saude Publica, 33(7); 10.1590/0102-311x00113316.

Regional Pharmacy Council of Paraná - CRF-PR (2016). Resolution No. 898/2016. Curitiba-PR.

Rocon, P. C. et al. (2018). What do trans people expect from the Unified Health System? Interface - Comunicação Saúde Educação;22(64):43–53; 10.1590/1807-57622016.0712.

Romanowski, F. F. A et al (2019). Manual de tipos de estudo. Produção técnica de pós-graduação em odontologia. Centro Universitário de Anápolis). Anápolis, Goiás.

Schwindt R. G. (2020). LGBTQ Cultural Competence for Pharmacists. Pharm. today, 26(9):46–55; 10.1016/j.ptdy.2020.08.018.

Silva, E. D. et al. (2021). Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy. Front Psychiatry, 10.3389/fpsyt.2021.621075.

Silva, R. A. et al. (2022). Use of Unprescribed Hormones in Body Modification of Travestis and Transsexual Women from Salvador/Bahia, Brazil. Cien Saude Colet, 27(2):503–514; 10.1590/1413-81232022272.44342020.

Spizzirri, G. et al. (2021). Proportion of People Identified as Transgender and Non-Binary Gender in Brazil. Sci Rep 2021;11(1):2240; 10.1038/s41598-021-81411-4.

Stepleman, L. M. et al. (2019). Health Needs and Experiences of a LGBT Population in Georgia and South Carolina. J Homosex, 66(7):989–1013; 10.1080/00918369.2018.1490573.

Streed, C. G. et al. (2017). Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review. Ann Intern Med,167(4):256; 10.7326/M17-0577.

Downloads

Publicado

24/11/2022

Como Citar

SILVA, C. M. L.; MATOS, L. E. O.; SASSAQUI, A. R.; ANDRADE, A. K. de S.; ROCHA, C. E.; BRITO, G. C. Perfil sociodemográfico e farmacoterapêutico de pessoas transgêneros acompanhadas por um serviço ambulatorial especializado no nordeste do Brasil. Research, Society and Development, [S. l.], v. 11, n. 15, p. e489111537659, 2022. DOI: 10.33448/rsd-v11i15.37659. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/37659. Acesso em: 17 jul. 2024.

Edição

Seção

Ciências da Saúde